Status:
RECRUITING
Study of the Effects of Anticoagulant Interruption Covered by Percutaneous Left Atrial Occlusion in Patients With Chronic Atrial Fibrillation and Radiation Cystitis at Risk of Bleeding
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Radiation Cystitis
Non-valvular Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
The etiology of the radiation cystitis is a pelvic irradiation generally performed as part of the treatment of prostate cancer. The incidence is 50,000 new cases per year. Approximately 35% of prostat...
Detailed Description
Prospective single-centre observational study involving the creation of a data registry of patients with anticoagulation-treated non-valvular atrial fibrillation with hematuria on radiation cystitis. ...
Eligibility Criteria
Inclusion
- Patient over 18 years old benefiting a social security sheme.
- Patient with hematuric radiation bladder associated with a non valvular anticoagulated atrial fibrillation.
Exclusion
- All the other hematuria's reasons
- Other reason of anti platelet agent using than atrial fibrillation
Key Trial Info
Start Date :
February 24 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2030
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04701749
Start Date
February 24 2021
End Date
September 1 2030
Last Update
April 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Clermont Ferrand
Clermont-Ferrand, France, 63003